_id
6915ec1abc934aba376b1d38
Ticker
RANI
Name
Rani Therapeutics Holdings Inc
Exchange
NASDAQ
Address
2051 Ringwood Avenue, San Jose, CA, United States, 95131
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.ranitherapeutics.com
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
Last Close
1.45
Volume
2259301
Current Price
1.365
Change
-5.862068965517239
Last Updated
2025-12-03T12:43:15.827Z
Image
-
Ipo Date
2021-07-30T00:00:00.000Z
Market Cap
169237376
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9864999999999999
Sentiment Sources
4
Rating
4.5
Target Price
9.25
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7257000
Operating Income
-7257000
Interest Expense
725000
Pretax Income
-7914000
Net Income
-5412000
Eps
-0.14810355207706202
Dividends Per Share
-
Shares Outstanding
97541221
Income Tax Expense
-
EBITDA
-6966000
Operating Margin
-
Total Other Income Expense Net
-657000
Cash
4144000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
4955000
Property Plant Equipment
4939000
Total Assets
10139000
Payables
2467000
Short Term Debt
14586000
Long Term Debt
-
Total Liabilities
22112000
Equity
-7860000
Depreciation
223000
Change In Working Capital
-260000
Cash From Operations
-5063000
Capital Expenditures
0
Cash From Investing
-150000
Cash From Financing
-1009000
Net Change In Cash
-6072000
PE
-
PB
-6.346034351145038
ROE
68.85496183206106
ROA
-53.378045172107704
FCF
-5063000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7257000
Quarters > 0 > income Statement > operating Income
-7257000
Quarters > 0 > income Statement > interest Expense
725000
Quarters > 0 > income Statement > pretax Income
-7914000
Quarters > 0 > income Statement > net Income
-5412000
Quarters > 0 > income Statement > eps
-0.14810355207706202
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
36542000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6966000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-657000
Quarters > 0 > balance Sheet > cash
4144000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4955000
Quarters > 0 > balance Sheet > property Plant Equipment
4939000
Quarters > 0 > balance Sheet > total Assets
10139000
Quarters > 0 > balance Sheet > payables
2467000
Quarters > 0 > balance Sheet > short Term Debt
14586000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
22112000
Quarters > 0 > balance Sheet > equity
-7860000
Quarters > 0 > cash Flow > net Income
-7914000
Quarters > 0 > cash Flow > depreciation
223000
Quarters > 0 > cash Flow > change In Working Capital
-260000
Quarters > 0 > cash Flow > cash From Operations
-5063000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-150000
Quarters > 0 > cash Flow > cash From Financing
-1009000
Quarters > 0 > cash Flow > net Change In Cash
-6072000
Quarters > 0 > ratios > PE
-0.14810355207706202
Quarters > 0 > ratios > PB
-6.346034351145038
Quarters > 0 > ratios > ROE
68.85496183206106
Quarters > 0 > ratios > ROA
-53.378045172107704
Quarters > 0 > ratios > FCF
-5063000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
240000
Quarters > 1 > income Statement > gross Profit
-240000
Quarters > 1 > income Statement > operating Expenses
10505000
Quarters > 1 > income Statement > operating Income
-10505000
Quarters > 1 > income Statement > interest Expense
877000
Quarters > 1 > income Statement > pretax Income
-11224000
Quarters > 1 > income Statement > net Income
-6692000
Quarters > 1 > income Statement > eps
-0.18313173882108258
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
36542000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-10107000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-719000
Quarters > 1 > balance Sheet > cash
10216000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
18000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
11073000
Quarters > 1 > balance Sheet > property Plant Equipment
5532000
Quarters > 1 > balance Sheet > total Assets
16898000
Quarters > 1 > balance Sheet > payables
1798000
Quarters > 1 > balance Sheet > short Term Debt
16189000
Quarters > 1 > balance Sheet > long Term Debt
2229000
Quarters > 1 > balance Sheet > total Liabilities
26051000
Quarters > 1 > balance Sheet > equity
-5575000
Quarters > 1 > cash Flow > net Income
-6692000
Quarters > 1 > cash Flow > depreciation
240000
Quarters > 1 > cash Flow > change In Working Capital
1216000
Quarters > 1 > cash Flow > cash From Operations
-5796000
Quarters > 1 > cash Flow > capital Expenditures
37000
Quarters > 1 > cash Flow > cash From Investing
5713000
Quarters > 1 > cash Flow > cash From Financing
188000
Quarters > 1 > cash Flow > net Change In Cash
105000
Quarters > 1 > ratios > PE
-0.18313173882108258
Quarters > 1 > ratios > PB
-8.947054708520179
Quarters > 1 > ratios > ROE
120.03587443946189
Quarters > 1 > ratios > ROA
-39.6023198011599
Quarters > 1 > ratios > FCF
-5833000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
172000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
172000
Quarters > 2 > income Statement > operating Expenses
12185000
Quarters > 2 > income Statement > operating Income
-12013000
Quarters > 2 > income Statement > interest Expense
943000
Quarters > 2 > income Statement > pretax Income
-12738000
Quarters > 2 > income Statement > net Income
-7264000
Quarters > 2 > income Statement > eps
-0.21722488038277513
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
33440000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-11544000
Quarters > 2 > income Statement > operating Margin
-6984.302325581395
Quarters > 2 > income Statement > total Other Income Expense Net
-725000
Quarters > 2 > balance Sheet > cash
10111000
Quarters > 2 > balance Sheet > short Term Investments
5742000
Quarters > 2 > balance Sheet > receivables
600000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17783000
Quarters > 2 > balance Sheet > property Plant Equipment
6096000
Quarters > 2 > balance Sheet > total Assets
24125000
Quarters > 2 > balance Sheet > payables
1520000
Quarters > 2 > balance Sheet > short Term Debt
16325000
Quarters > 2 > balance Sheet > long Term Debt
5921000
Quarters > 2 > balance Sheet > total Liabilities
29474000
Quarters > 2 > balance Sheet > equity
-3056000
Quarters > 2 > cash Flow > net Income
-7264000
Quarters > 2 > cash Flow > depreciation
251000
Quarters > 2 > cash Flow > change In Working Capital
28000
Quarters > 2 > cash Flow > cash From Operations
-8148999
Quarters > 2 > cash Flow > capital Expenditures
51000
Quarters > 2 > cash Flow > cash From Investing
18229000
Quarters > 2 > cash Flow > cash From Financing
-3731000
Quarters > 2 > cash Flow > net Change In Cash
6349000
Quarters > 2 > ratios > PE
-0.21722488038277513
Quarters > 2 > ratios > PB
-14.936387434554975
Quarters > 2 > ratios > ROE
237.69633507853402
Quarters > 2 > ratios > ROA
-30.10984455958549
Quarters > 2 > ratios > FCF
-8199999
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-47.67441279069767
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1028000
Quarters > 3 > income Statement > cost Of Revenue
266000
Quarters > 3 > income Statement > gross Profit
1028000
Quarters > 3 > income Statement > operating Expenses
15986000
Quarters > 3 > income Statement > operating Income
-14958000
Quarters > 3 > income Statement > interest Expense
1124000
Quarters > 3 > income Statement > pretax Income
-15722000
Quarters > 3 > income Statement > net Income
-8947000
Quarters > 3 > income Statement > eps
-0.273943661971831
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
32660000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-14332000
Quarters > 3 > income Statement > operating Margin
-1455.058365758755
Quarters > 3 > income Statement > total Other Income Expense Net
-764000
Quarters > 3 > balance Sheet > cash
3762000
Quarters > 3 > balance Sheet > short Term Investments
23877000
Quarters > 3 > balance Sheet > receivables
428000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
29744000
Quarters > 3 > balance Sheet > property Plant Equipment
6644000
Quarters > 3 > balance Sheet > total Assets
36634000
Quarters > 3 > balance Sheet > payables
1359000
Quarters > 3 > balance Sheet > short Term Debt
16459000
Quarters > 3 > balance Sheet > long Term Debt
9613000
Quarters > 3 > balance Sheet > total Liabilities
33141000
Quarters > 3 > balance Sheet > equity
1992000
Quarters > 3 > cash Flow > net Income
-15722000
Quarters > 3 > cash Flow > depreciation
266000
Quarters > 3 > cash Flow > change In Working Capital
-1132000
Quarters > 3 > cash Flow > cash From Operations
-8655000
Quarters > 3 > cash Flow > capital Expenditures
31000
Quarters > 3 > cash Flow > cash From Investing
2521000
Quarters > 3 > cash Flow > cash From Financing
5619000
Quarters > 3 > cash Flow > net Change In Cash
-515000
Quarters > 3 > ratios > PE
-0.273943661971831
Quarters > 3 > ratios > PB
22.37996987951807
Quarters > 3 > ratios > ROE
-449.1465863453815
Quarters > 3 > ratios > ROA
-24.42266746738003
Quarters > 3 > ratios > FCF
-8686000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-8.449416342412452
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1028000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
1028000
Annuals > 0 > income Statement > operating Expenses
54342000
Annuals > 0 > income Statement > operating Income
-53314000
Annuals > 0 > income Statement > interest Expense
5033000
Annuals > 0 > income Statement > pretax Income
-30018000
Annuals > 0 > income Statement > net Income
-30018000
Annuals > 0 > income Statement > eps
-1.0541508638853772
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
28476000
Annuals > 0 > income Statement > income Tax Expense
26566000
Annuals > 0 > income Statement > EBITDA
-50523000
Annuals > 0 > income Statement > operating Margin
-5186.186770428016
Annuals > 0 > income Statement > total Other Income Expense Net
23296000
Annuals > 0 > balance Sheet > cash
3762000
Annuals > 0 > balance Sheet > short Term Investments
23877000
Annuals > 0 > balance Sheet > receivables
428000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
29744000
Annuals > 0 > balance Sheet > property Plant Equipment
6644000
Annuals > 0 > balance Sheet > total Assets
36634000
Annuals > 0 > balance Sheet > payables
1359000
Annuals > 0 > balance Sheet > short Term Debt
16459000
Annuals > 0 > balance Sheet > long Term Debt
9613000
Annuals > 0 > balance Sheet > total Liabilities
33141000
Annuals > 0 > balance Sheet > equity
1992000
Annuals > 0 > cash Flow > net Income
-56584000
Annuals > 0 > cash Flow > depreciation
1028000
Annuals > 0 > cash Flow > change In Working Capital
-544000
Annuals > 0 > cash Flow > cash From Operations
-35496000
Annuals > 0 > cash Flow > capital Expenditures
268000
Annuals > 0 > cash Flow > cash From Investing
19809000
Annuals > 0 > cash Flow > cash From Financing
13585000
Annuals > 0 > cash Flow > net Change In Cash
-2102000
Annuals > 0 > ratios > PE
-1.0541508638853772
Annuals > 0 > ratios > PB
19.72734939759036
Annuals > 0 > ratios > ROE
-1506.9277108433735
Annuals > 0 > ratios > ROA
-81.94027406234645
Annuals > 0 > ratios > FCF
-35764000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-34.78988326848249
Annuals > 0 > health Score
9
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
822000
Annuals > 1 > income Statement > gross Profit
-822000
Annuals > 1 > income Statement > operating Expenses
65277000
Annuals > 1 > income Statement > operating Income
-66099000
Annuals > 1 > income Statement > interest Expense
5085000
Annuals > 1 > income Statement > pretax Income
-67883000
Annuals > 1 > income Statement > net Income
-33970000
Annuals > 1 > income Statement > eps
-1.3318957067241717
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
25505000
Annuals > 1 > income Statement > income Tax Expense
-33913000
Annuals > 1 > income Statement > EBITDA
-65277000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1784000
Annuals > 1 > balance Sheet > cash
5864000
Annuals > 1 > balance Sheet > short Term Investments
42675000
Annuals > 1 > balance Sheet > receivables
200000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
50847000
Annuals > 1 > balance Sheet > property Plant Equipment
6823000
Annuals > 1 > balance Sheet > total Assets
57916000
Annuals > 1 > balance Sheet > payables
648000
Annuals > 1 > balance Sheet > short Term Debt
5615000
Annuals > 1 > balance Sheet > long Term Debt
24484000
Annuals > 1 > balance Sheet > total Liabilities
32473000
Annuals > 1 > balance Sheet > equity
12866000
Annuals > 1 > cash Flow > net Income
-33970000
Annuals > 1 > cash Flow > depreciation
822000
Annuals > 1 > cash Flow > change In Working Capital
-2140000
Annuals > 1 > cash Flow > cash From Operations
-51236000
Annuals > 1 > cash Flow > capital Expenditures
1229000
Annuals > 1 > cash Flow > cash From Investing
29860000
Annuals > 1 > cash Flow > cash From Financing
233000
Annuals > 1 > cash Flow > net Change In Cash
-21143000
Annuals > 1 > ratios > PE
-1.3318957067241717
Annuals > 1 > ratios > PB
2.7356521063267523
Annuals > 1 > ratios > ROE
-264.0292243121405
Annuals > 1 > ratios > ROA
-58.6539125630223
Annuals > 1 > ratios > FCF
-52465000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
21
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1312000
Annuals > 2 > income Statement > gross Profit
-1312000
Annuals > 2 > income Statement > operating Expenses
63451000
Annuals > 2 > income Statement > operating Income
-63451000
Annuals > 2 > income Statement > interest Expense
1071000
Annuals > 2 > income Statement > pretax Income
-63274000
Annuals > 2 > income Statement > net Income
-30588000
Annuals > 2 > income Statement > eps
-1.2842927320821262
Annuals > 2 > income Statement > dividends Per Share
29631000
Annuals > 2 > income Statement > shares Outstanding
23817000
Annuals > 2 > income Statement > income Tax Expense
70000
Annuals > 2 > income Statement > EBITDA
-61655000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
177000
Annuals > 2 > balance Sheet > cash
27007000
Annuals > 2 > balance Sheet > short Term Investments
71475000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
100924000
Annuals > 2 > balance Sheet > property Plant Equipment
7103000
Annuals > 2 > balance Sheet > total Assets
108027000
Annuals > 2 > balance Sheet > payables
1460000
Annuals > 2 > balance Sheet > short Term Debt
1006000
Annuals > 2 > balance Sheet > long Term Debt
29149000
Annuals > 2 > balance Sheet > total Liabilities
34023000
Annuals > 2 > balance Sheet > equity
36855000
Annuals > 2 > cash Flow > net Income
-63344000
Annuals > 2 > cash Flow > depreciation
548000
Annuals > 2 > cash Flow > change In Working Capital
509000
Annuals > 2 > cash Flow > cash From Operations
-46515000
Annuals > 2 > cash Flow > capital Expenditures
1619000
Annuals > 2 > cash Flow > cash From Investing
-72436000
Annuals > 2 > cash Flow > cash From Financing
29005000
Annuals > 2 > cash Flow > net Change In Cash
-89946000
Annuals > 2 > ratios > PE
-1.2842927320821262
Annuals > 2 > ratios > PB
0.8918046398046396
Annuals > 2 > ratios > ROE
-82.995522995523
Annuals > 2 > ratios > ROA
-28.315143436363133
Annuals > 2 > ratios > FCF
-48134000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2717000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
2717000
Annuals > 3 > income Statement > operating Expenses
54316000
Annuals > 3 > income Statement > operating Income
-51599000
Annuals > 3 > income Statement > interest Expense
466000
Annuals > 3 > income Statement > pretax Income
-53047000
Annuals > 3 > income Statement > net Income
-8331000
Annuals > 3 > income Statement > eps
-0.42648715060919423
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19534000
Annuals > 3 > income Statement > income Tax Expense
41000
Annuals > 3 > income Statement > EBITDA
-52084000
Annuals > 3 > income Statement > operating Margin
-1899.1166728008832
Annuals > 3 > income Statement > total Other Income Expense Net
-1448000
Annuals > 3 > balance Sheet > cash
117453000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
119595000
Annuals > 3 > balance Sheet > property Plant Equipment
4612000
Annuals > 3 > balance Sheet > total Assets
124207000
Annuals > 3 > balance Sheet > payables
1080000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2640001
Annuals > 3 > balance Sheet > equity
47410999
Annuals > 3 > cash Flow > net Income
-8331000
Annuals > 3 > cash Flow > depreciation
497000
Annuals > 3 > cash Flow > change In Working Capital
-3429000
Annuals > 3 > cash Flow > cash From Operations
-32245000
Annuals > 3 > cash Flow > capital Expenditures
506000
Annuals > 3 > cash Flow > cash From Investing
-506000
Annuals > 3 > cash Flow > cash From Financing
77146000
Annuals > 3 > cash Flow > net Change In Cash
44395000
Annuals > 3 > ratios > PE
-0.42648715060919423
Annuals > 3 > ratios > PB
0.5685794555816045
Annuals > 3 > ratios > ROE
-17.571871877240973
Annuals > 3 > ratios > ROA
-6.707351437519625
Annuals > 3 > ratios > FCF
-32751000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-12.054103790945897
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.14810355207706202
Valuation > metrics > PB
-6.346034351145038
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
68.85496183206106
Profitability > metrics > ROA
-109.22300706357215
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-10.009655172413794
Risk > final Score
-10
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.29056471002169704
Liquidity > metrics > Quick Ratio
0.29056471002169704
Liquidity > final Score
25
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
55
Prev Profitabilities > 1
40
Prev Profitabilities > 2
0
Prev Risks > 0
-18
Prev Risks > 1
-21
Prev Risks > 2
-47
Prev Liquidities > 0
41
Prev Liquidities > 1
60
Prev Liquidities > 2
92
Updated At
2025-12-16T23:14:20.141Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.12
Earnings History > 0 > eps Estimate
-0.1667
Earnings History > 0 > eps Difference
0.0467
Earnings History > 0 > surprise Percent
28.0144
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.18
Earnings History > 1 > eps Estimate
-0.29
Earnings History > 1 > eps Difference
0.11
Earnings History > 1 > surprise Percent
37.931
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-29
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.2739
Earnings History > 2 > eps Estimate
-0.24
Earnings History > 2 > eps Difference
-0.0339
Earnings History > 2 > surprise Percent
-14.125
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.27
Earnings History > 3 > eps Estimate
-0.26
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-3.8462
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.24
Earnings History > 4 > eps Estimate
-0.26
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
7.6923
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.26
Earnings History > 5 > eps Estimate
-0.32
Earnings History > 5 > eps Difference
0.06
Earnings History > 5 > surprise Percent
18.75
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-06
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.29
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
-0.09
Earnings History > 6 > surprise Percent
-45
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.27
Earnings History > 7 > eps Estimate
-0.31
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
12.9032
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.36
Earnings History > 8 > eps Estimate
-0.37
Earnings History > 8 > eps Difference
0.01
Earnings History > 8 > surprise Percent
2.7027
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.37
Earnings History > 9 > eps Estimate
-0.4
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
7.5
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.33
Earnings History > 10 > eps Estimate
-0.41
Earnings History > 10 > eps Difference
0.08
Earnings History > 10 > surprise Percent
19.5122
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.35
Earnings History > 11 > eps Estimate
-0.35
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.33
Earnings History > 12 > eps Estimate
-0.47
Earnings History > 12 > eps Difference
0.14
Earnings History > 12 > surprise Percent
29.7872
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-10
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.31
Earnings History > 13 > eps Estimate
-0.58
Earnings History > 13 > eps Difference
0.27
Earnings History > 13 > surprise Percent
46.5517
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.29
Earnings History > 14 > eps Estimate
-0.66
Earnings History > 14 > eps Difference
0.37
Earnings History > 14 > surprise Percent
56.0606
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-29
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.27
Earnings History > 15 > eps Estimate
-0.49
Earnings History > 15 > eps Difference
0.22
Earnings History > 15 > surprise Percent
44.898
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.12
Earnings History > 16 > eps Estimate
-0.18
Earnings History > 16 > eps Difference
0.06
Earnings History > 16 > surprise Percent
33.3333
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.12
Earnings History > 17 > eps Estimate
-0.18
Earnings History > 17 > eps Difference
0.06
Earnings History > 17 > surprise Percent
33.3333
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-02
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.115
Earnings History > 18 > eps Estimate
-0.12
Earnings History > 18 > eps Difference
0.005
Earnings History > 18 > surprise Percent
4.1667
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.1194
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.1194
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2020-03-31
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.1141
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.1141
Earnings History > 20 > surprise Percent
-
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADip Buying: Will RANI stock return to pre crisis levels - Earnings Summary Report & Scalable Portfolio Growth Methods moha.gov.vn
Read more →Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3% - Here's Why MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$9.25
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 14.38% of the total shares of Rani Therapeutics Holdings Inc
1.
Armistice Capital, LLC(6.5793%)
since
2025/06/30
2.
Vanguard Group Inc(1.6695%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.0598%)
since
2025/07/31
4.
United Services Automobile Association(0.6321%)
since
2025/06/30
5.
Takeda Pharmaceutical Co Ltd(0.4242%)
since
2025/06/30
6.
Geode Capital Management, LLC(0.3978%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.377%)
since
2025/07/31
8.
KESTRA PRIVATE WEALTH SERVICES, LLC(0.326%)
since
2025/06/30
9.
Citadel Advisors Llc(0.2868%)
since
2025/06/30
10.
BlackRock Inc(0.2477%)
since
2025/06/30
11.
Northern Trust Corp(0.2149%)
since
2025/06/30
12.
Fidelity Extended Market Index(0.2016%)
since
2025/07/31
13.
CWA Asset Management Group, LLC(0.174%)
since
2025/06/30
14.
Lasry Marc(0.1313%)
since
2025/06/30
15.
State Street Corp(0.1304%)
since
2025/06/30
16.
UBS Group AG(0.1296%)
since
2025/06/30
17.
King Luther Capital Management Corp(0.1211%)
since
2025/06/30
18.
Janney Montgomery Scott LLC(0.1152%)
since
2025/06/30
19.
Well Done, LLC(0.1086%)
since
2025/06/30
20.
iShares Micro-Cap ETF(0.1047%)
since
2025/08/31
21.
Motco(0.1005%)
since
2025/06/30
22.
Insigneo Advisory Services LLC(0.0992%)
since
2025/06/30
23.
Bridgeway Capital Management, LLC(0.0971%)
since
2025/06/30
24.
Bridgeway Ultra-Small Company Market(0.0971%)
since
2025/06/30
25.
Brown Advisory Holdings Inc(0.0687%)
since
2025/06/30
26.
Fidelity Series Total Market Index(0.056%)
since
2025/07/31
27.
Fidelity Total Market Index(0.0545%)
since
2025/07/31
28.
Spartan Extended Market Index Pool F(0.0507%)
since
2025/07/31
29.
Northern Small Cap Core I(0.0462%)
since
2025/06/30
30.
Northern Trust Extended Eq Market Idx(0.0339%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - L(0.0339%)
since
2025/06/30
32.
Extended Equity Market Fund K(0.0332%)
since
2025/06/30
33.
NT Ext Equity Mkt Idx Fd - NL(0.0303%)
since
2025/06/30
34.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0297%)
since
2024/12/31
35.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0235%)
since
2025/06/30
36.
NT Quality Small Cap Core(0.0226%)
since
2025/06/30
37.
NT Quality SCC US Fund - L(0.0226%)
since
2025/06/30
38.
Spartan Total Market Index Pool G(0.0199%)
since
2025/07/31
39.
Fidelity Nasdaq Composite Index(0.015%)
since
2025/07/31
40.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0096%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.12
EPS Estimate
-0.1667
EPS Difference
0.0467
Surprise Percent
28.0144%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.